Literature DB >> 6684716

Effects of inducers of erythroid differentiation of human leukemia K562 cells on vincristine-resistant K562/VCR cells.

J Okabe-Kado, M Hayashi, Y Honma, M Hozumi, T Tsuruo.   

Abstract

K562/VCR cells, which are resistant to the cytotoxicity of vincristine, were isolated from human erythroleukemia K562 cells. Various compounds that induce erythroid differentiation of K562 cells were tested on K562/VCR cells. Differentiation of K562/VCR cells was not induced by actinomycin D or adriamycin alone, but the resistance of these cells to the inducers was overcome by verapamil. In contrast, mitomycin C, butyric acid and hemin induced differentiation of K562/VCR cells as effectively as that of K562 cells. These results suggest that therapy by induction of differentiation of leukemic cells is effective for leukemic cells that have acquired resistance to therapeutic drugs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6684716     DOI: 10.1016/0145-2126(83)90043-7

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  5 in total

1.  Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation.

Authors:  Takao Shishido; Frank Wolschendorf; Alexandra Duverger; Frederic Wagner; John Kappes; Jennifer Jones; Olaf Kutsch
Journal:  J Virol       Date:  2012-06-13       Impact factor: 5.103

2.  Sensitivity of K562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs and differentiating agents.

Authors:  W N Hait; S Choudhury; S Srimatkandada; J R Murren
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

3.  Adriamycin induced resistance of sensitive K 562 cells to natural killer lymphocyte attack.

Authors:  H Benoist; C Madoulet; J C Jardillier; A Desplaces
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

4.  Inhibition of abl oncogene tyrosine kinase induces erythroid differentiation of human myelogenous leukemia K562 cells.

Authors:  Y Honma; J Okabe-Kado; T Kasukabe; M Hozumi; K Umezawa
Journal:  Jpn J Cancer Res       Date:  1990-11

5.  Increase in the level of P-glycoprotein mRNA expression in multidrug-resistant K562 cell lines treated with sodium butyrate is not accompanied with erythroid differentiation.

Authors:  H Shibata; R Kanamaru; T Sato; C Ishioka; Y Konishi; A Ishikawa; A Wakui; T Tsuruo
Journal:  Jpn J Cancer Res       Date:  1990-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.